Picard Medical, Inc.
Income Statement
| Line Item | FY2025 | FY2024 |
|---|---|---|
| Revenue | $4.9M | $4.4M |
| Cost of Revenue | $5.1M | $4.5M |
| Gross Profit | $-204.0K | $-112.0K |
| Gross Margin | -4.1% | -2.6% |
| Operating Expenses | ||
| Research & Development | $3.0M | $3.4M |
| SG&A Expense | $10.0M | $10.2M |
| Operating Income | $-13.3M | $-13.7M |
| Operating Margin | -268.4% | -312.3% |
| Interest Expense | — | — |
| Pretax Income | $-27.0M | $-21.1M |
| Income Tax Expense | $35.0K | $-15.0K |
| Net Income | $-27.0M | $-21.1M |
| Net Margin | -546.6% | -479.5% |
| EPS (Basic) | $-0.75 | $-0.60 |
| EPS (Diluted) | — | — |
| Shares Outstanding (Basic) | 36.2M | 39.7M |
| Shares Outstanding (Diluted) | 36.2M | 39.7M |
| Dividends Per Share | — | — |